Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Xerostomia 1Stomatitis 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Xylitol × Clear all
NCT04608773 2024-02-01

Blinded Dry Mouth Spray Crossover Study

University of Pittsburgh

Phase NA Completed
129 enrolled 12 charts
Head & Neck

Head and Neck Neoplasms, Xerostomia

NCT01898091 2017-03-06

OM

Medical University of South Carolina

Phase 2 Completed
50 enrolled 9 charts
Other

Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡